Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy of tivozanib treatment after sorafenib in patients with advanced renal cell carcinoma: crossover of a phase 3 study.
Molina AM, Hutson TE, Nosov D, Tomczak P, Lipatov O, Sternberg CN, Motzer R, Eisen T. Molina AM, et al. Eur J Cancer. 2018 May;94:87-94. doi: 10.1016/j.ejca.2018.02.009. Epub 2018 Mar 20. Eur J Cancer. 2018. PMID: 29547835 Free PMC article. Clinical Trial.
Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma.
Eisen T, Trefzer U, Hamilton A, Hersey P, Millward M, Knight RD, Jungnelius JU, Glaspy J. Eisen T, et al. Cancer. 2010 Jan 1;116(1):146-54. doi: 10.1002/cncr.24686. Cancer. 2010. PMID: 19862820 Clinical Trial.
Modern myths of percutaneous renal tumour mass biopsy.
Connolly SS, Koo B, Warren AY, Eisen T. Connolly SS, et al. BJU Int. 2015 Jan;115(1):8-9. doi: 10.1111/bju.12648. BJU Int. 2015. PMID: 24471862 No abstract available.
Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study.
Colomba E, Le Teuff G, Eisen T, Stewart GD, Fife K, Larkin J, Biondo A, Pickering L, Srinivasan A, Boyle H, Derosa L, Sternberg CN, Recine F, Ralph C, Saldana C, Barthélémy P, Bernhard JC, Gurney H, Verhoest G, Vauleon E, Bigot P, Berger J, Pfister C, Gravis G, Rodier JM, Culine S, Caty A, Rolland F, Priou F, Escudier B, Albiges L. Colomba E, et al. Eur J Cancer. 2017 Jul;80:55-62. doi: 10.1016/j.ejca.2017.03.011. Epub 2017 May 23. Eur J Cancer. 2017. PMID: 28549248 Clinical Trial.
Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer.
Parton M, Gore M, Eisen T. Parton M, et al. J Clin Oncol. 2006 Dec 10;24(35):5584-92. doi: 10.1200/JCO.2006.08.1638. J Clin Oncol. 2006. PMID: 17158544 Review.
Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial.
Eisen T, Joensuu H, Nathan PD, Harper PG, Wojtukiewicz MZ, Nicholson S, Bahl A, Tomczak P, Pyrhonen S, Fife K, Bono P, Boxall J, Wagner A, Jeffers M, Lin T, Quinn DI. Eisen T, et al. Lancet Oncol. 2012 Oct;13(10):1055-62. doi: 10.1016/S1470-2045(12)70364-9. Epub 2012 Sep 6. Lancet Oncol. 2012. PMID: 22959186 Clinical Trial.
Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer.
Eisen T, Thatcher N, Leyvraz S, Miller WH Jr, Couture F, Lorigan P, Lüthi F, Small D, Tanovic A, O'Brien M. Eisen T, et al. Lung Cancer. 2009 Apr;64(1):60-5. doi: 10.1016/j.lungcan.2008.06.017. Epub 2008 Aug 9. Lung Cancer. 2009. PMID: 18692272 Clinical Trial.
22 results
Jump to page
Feedback